Lisinopril
- TRADE NAME: Acerbon; Alapril; Carace; Coric; Prinil; Prinivil (Merck); Prinzide (Merck); Tensopril; Vivatec; Zestoretic (AstraZeneca); Zestril (AstraZeneca)
- INDICATIONS: Hypertension; as adjunctive therapy in the management of heart failure; short-term treatment following myocardial infarction in hemodynamically stable patients
- CLASS: Angiotensin-converting enzyme (ACE) inhibitor
- HALF-LIFE: 12 hours
Alcohol, Aldesleukin, Allopurinol, Alpha blockers, Alprostadil, Amifostine, Amiloride, Angiotensin II receptor antagonists, Antacids, Antidiabetics, Antihypertensives, Antipsychotics, Anxiolytics and hypnotics, Aprotinin, Azathioprine, Baclofen, Beta blockers, Calcium channel blockers, Clonidine, Corticosteroids, Cyclosporine, Diazoxide, Diuretics, Eplerenone, Estrogens, Everolimus, Garlic, General anesthetics, Gold and Gold Compounds, Heparins, Herbals, Hydralazine, Hypotensives, Insulin, Levodopa, Liraglutide, Lithium, MAO inhibitors, Metformin, Methyldopa, Methylphenidate, Minoxidil, Moxisylyte, Moxonidine, Nitrates, Nitroprusside, NSAIDs, Pentoxifylline, Phosphodiesterase 5 inhibitors, Potassium salts, Prostacyclin analogues, Rituximab, Salicylates, Sirolimus, Spironolactone, Sulfonylureas, Temsirolimus, Tizanidine, Tolvaptan, Triamterene, Trimethoprim, Yohimbine
PREGNANCY CATEGORY: D
category C in first trimester; category D in second and third trimesters
Contraindicated in patients with a history of angioedema related to previous treatment with an ACE inhibitor and in patients with hereditary or idiopathic angioedema.
Safety and effectiveness in pediatric patients <6 years of age have not been established.
Prinzide and Zestoretic are lisinopril and hydrochlorothiazide.
Please login to see the rest of this drug profile
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life Threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric